Cytoscient
Cytoscient offers expert services for pharmaceutical and biomarker development, with extensive experience in drug discovery, toxicology, and clinical trials. Their mission is to provide high quality, cost-effective, and rapid data to support decision making throughout drug development stages.
Industries
Nr. of Employees
small (1-50)
Cytoscient
Berkeley, California, United States, North America
Services
Advisory services for candidate selection, preclinical package preparation, clinical trial design, and preparation of regulatory submissions (IND/NDA/BLA) and related documentation.
Laboratory analysis of therapeutic and metabolite concentrations in biological samples using LC-MS/MS to support preclinical PK and dose selection.
Integrated in vitro ADME testing including metabolic stability, reaction phenotyping, metabolite profiling, enzyme inhibition/induction, transporter inhibition, and protein binding to characterize clearance and interaction risk.
Cell-based testing services for cytotoxicity, phototoxicity and biomarker assays to evaluate cellular responses and safety signals in multiple cell models.
Proteomic and genomic biomarker discovery and quantification to support translational studies and clinical development decisions.
Advisory services for candidate selection, preclinical package preparation, clinical trial design, and preparation of regulatory submissions (IND/NDA/BLA) and related documentation.
Laboratory analysis of therapeutic and metabolite concentrations in biological samples using LC-MS/MS to support preclinical PK and dose selection.
Integrated in vitro ADME testing including metabolic stability, reaction phenotyping, metabolite profiling, enzyme inhibition/induction, transporter inhibition, and protein binding to characterize clearance and interaction risk.
Cell-based testing services for cytotoxicity, phototoxicity and biomarker assays to evaluate cellular responses and safety signals in multiple cell models.
Proteomic and genomic biomarker discovery and quantification to support translational studies and clinical development decisions.
Expertise Areas
- DMPK and ADME
- PK bioanalysis and quantitative mass spectrometry
- Drug metabolism and metabolite identification
- Drug–drug interaction assessment and prediction
Key Technologies
- Liquid chromatography–tandem mass spectrometry (LC-MS/MS)
- Mass spectrometry-based metabolite identification
- RT-qPCR for gene expression/induction assays
- Equilibrium dialysis for protein binding
News & Updates
Drug candidate development and clinical trial planning
Cytoscient provides comprehensive preclinical data and clinical trial design support.
Drug candidate development and clinical trial planning
Cytoscient provides comprehensive preclinical data and clinical trial design support.